Sanara MedTech, Inc. (SMTI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 21, 2025

$34.00

P/E Ratio

N/A

Market Cap

$297.2M

Jan 25, 2024Feb 29, 2024Apr 3, 2024May 6, 2024Jun 10, 2024Jul 16, 2024Aug 19, 2024Sep 24, 2024Oct 29, 2024Dec 3, 2024Jan 21, 2025$0.00$10.00
  • DWSN
Description

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Metrics

Overview

  • HQFort Worth, TX
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerSMTI
  • Price$34+4.17%

Trading Information

  • Market cap$297.20M
  • Float34.64%
  • Average Daily Volume (1m)26,318
  • Average Daily Volume (3m)31,363
  • EPS-$0.99

Company

  • Revenue$78.06M
  • Rev growth (1yr)35.24%
  • Net income-$2.86M
  • Gross margin85.71%
  • EBITDA margin-3.11%
  • EBITDA-$0.67M
  • EV$272.88M
  • EV/Revenue3.50
  • P/EN/A
  • P/S3.71
  • P/B7.47
Documents